Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma

ROCHESTER, Minn. — The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology. R-CHOP is a combination of drugs used to treat lymphoma. The combination includes rituximab, cyclophosphamide, doxorubicin, vincristine and [...]
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news